Search - tctmd.com

Displaying 281 - 296 of 296

Sort: Relevancy | Date

News Daily News

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

March 06, 2012

News Daily News

PARTNER: TAVR Cost-Effectiveness Evaluated in Inoperable Patients

Leah Lawrence

February 09, 2012

News Daily News

Women Benefit From TAVR as Much as Men, Maybe More

Jason Kahn

January 29, 2012

News Daily News

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Jason Kahn

January 04, 2012

News Daily News

Repositionable Valve Yields Promising 2-Year TAVR Results

December 06, 2011

News Daily News

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

October 06, 2011

News Daily News

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

October 03, 2011

News Daily News

TAVR Travelers: Medical Tourism Gaining Ground

L.A. McKeown

September 26, 2011

News Daily News

TAVI Appears Safe for Patients with Small Annuli

August 22, 2011

News Daily News

FDA Panel Recommends Approval of Transcatheter Heart Valve

July 21, 2011

News Daily News

PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery

L.A. McKeown

June 07, 2011

News Conference News

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

April 04, 2011

News Daily News

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

L.A. McKeown

January 13, 2011

News

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

TCT Daily Staff

September 23, 2010

News Daily News

EVEREST: MitraClip Safe, Effective for Mitral Valve Repair

TCT Daily Staff

September 23, 2009

News Conference News

TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Shelley Wood

April 10, 2001

Advertisement

Patient Selection Trends Younger, Less High Risk for Transcatheter Valve Therapy

PARTNER: TAVR Cost-Effectiveness Evaluated in Inoperable Patients

Women Benefit From TAVR as Much as Men, Maybe More

EVEREST II Registry Looks at MitraClip in High-Risk Patients

Repositionable Valve Yields Promising 2-Year TAVR Results

PARTNER: Quality of Life Greatly Improved by Transcatheter Valve Procedure

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

TAVR Travelers: Medical Tourism Gaining Ground

TAVI Appears Safe for Patients with Small Annuli

FDA Panel Recommends Approval of Transcatheter Heart Valve

PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery

EVEREST II: Two-Year Outcomes Show Positive, Negative Aspects of MitraClip

Different Factors Linked to Early, Late Mortality with CoreValve TAVI

PARTNER: All-Cause, CV Mortality Lower in Patients Treated with TAVI vs. Standard Therapy at 1 Year

EVEREST: MitraClip Safe, Effective for Mitral Valve Repair

TEST - COAPT Quality-of-Life Analysis Points to Significant, Sustained Benefits in Health Status With MitraClip

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content